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Background: While peak CK-MB and troponin levels have been correlated with mortality among patients with acute myocardial infarction, the 
independent prognostic implications of these markers have not been compared.
Methods: We examined ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) patients in ACTION Registry-GWTG with 
both CK-MB and troponin I (TnI) levels recorded and excluded those who were transferred in or out. Peak marker levels, standardized by the local 
laboratory upper limit of normal (ULN) and assay standard deviation, were fitted into the previously validated ACTION-GWTG mortality model to 
compare prognostic value.
Results: Between Jan 2007 and March 2009, 16,009 STEMI and 26,854 NSTEMI patients were identified. Median peak CK-MB and TnI levels were 
22.2 and 174.8 xULN in STEMI and 4.3 and 33.7 xULN in NSTEMI patients, respectively. Peak CK-MB and TnI ratios were directly associated with 
in-hospital mortality in both STEMI and NSTEMI patients, however this was limited at lower marker levels in STEMI patients (Figure). 
Peak CK-MB had greater discrimination in predicting adjusted mortality in both STEMI (model c-statistic 0.881 v. 0.877, p=0.011) and NSTEMI 
(model c-statistic 0.831 v. 0.824, p=0.001) patients.
Conclusions: Peak CK-MB levels discriminate in hospital mortality better than troponin in both STEMI and NSTEMI patients. Thus, serial 
measurements of CK-MB during hospitalization may better guide risk stratification and treatment intensity post-MI.
